Putin understands FIFA in a way most other heads of state don't
The sitcom's current syndication deals expire this fall, which puts its streaming rights into play.
And yet for some inexplicable reason, Congress keeps asking the Defense Department to do more things, including scientific research and global infrastructure projects.
A proposed law would compel companies to add digital protection
The boss of investment bank Bear Stearns until 1993, he was embittered about the firm's near collapse in 2008
An incredulous local banker turned the state's first brewmasters down for a loan, asking “You’re going to sell a bunch of froufrou beer to South Mississippians?”
Karen Mills says the Consumer Financial Protection Bureau could rein in high-cost credit, but that might hamper innovation
Founder: Dr. John Hadden
VC Investment over the last four quarters: $25 million
IRX Therapeutics is a 40-employee biotech firm developing drugs to restore immune system function, particularly in patients with head and neck cancer. Founded over a decade ago and backed by more than $60 million raised mostly from high-net-worth individuals, the company has reduced headcount by a third and delayed some clinical trials planned for 2009, according to Chief Financial Officer Jeffrey Hwang.
Key to startup success: "In normal times where the capital is available, the difference maker among people with good ideas is sharp execution. There's never a substitute for the ability to attract and retain experienced, qualified people to take advantage of the discovery you've made."